KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vir Biotechnology (VIR) Revenue (2018 - 2025)

Vir Biotechnology (VIR) has disclosed Revenue for 8 consecutive years, with $64.1 million as the latest value for Q4 2025.

  • Quarterly Revenue rose 417.78% to $64.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $68.6 million through Dec 2025, down 1.4% year-over-year, with the annual reading at $68.6 million for FY2025, 7.61% down from the prior year.
  • Revenue hit $64.1 million in Q4 2025 for Vir Biotechnology, up from $240000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $1.2 billion in Q1 2022 to a low of $240000.0 in Q3 2025.
  • Historically, Revenue has averaged $150.4 million across 5 years, with a median of $28.7 million in 2022.
  • Biggest five-year swings in Revenue: soared 62271.41% in 2022 and later crashed 99.3% in 2023.
  • Year by year, Revenue stood at $812.7 million in 2021, then tumbled by 93.92% to $49.4 million in 2022, then tumbled by 66.03% to $16.8 million in 2023, then dropped by 26.29% to $12.4 million in 2024, then surged by 417.78% to $64.1 million in 2025.
  • Business Quant data shows Revenue for VIR at $64.1 million in Q4 2025, $240000.0 in Q3 2025, and $1.2 million in Q2 2025.